# Evolent Health (EVH) — Analyst Forecast

EVH · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/evh/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 11 | 3 | 0 | 14 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $6.00 | $6.00 | $6.00 | 5 |

Last price $4.87 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 18, 2026 | JP Morgan | Maintained | Overweight | $6.00 |
| Aug 17, 2026 | TD Cowen | Maintained | Buy | $6.00 |
| Aug 12, 2026 | Truist Securities | Maintained | Hold | $6.00 |
| Aug 11, 2026 | Citigroup | Upgraded | Neutral → Buy | $6.00 |
| Aug 10, 2026 | Canaccord Genuity | Maintained | Buy | $6.00 |
| Jul 28, 2026 | TD Cowen | Maintained | Buy | $5.00 |
| Jul 23, 2026 | Citigroup | Downgraded | Buy → Neutral | $6.75 |
| Jul 21, 2026 | Canaccord Genuity | Maintained | Buy | $7.00 |
| Jun 30, 2026 | Truist Securities | Downgraded | Buy → Hold | $7.00 |
| Jun 12, 2026 | Truist Securities | Maintained | Buy | $7.00 |
| May 15, 2026 | Citigroup | Maintained | Buy | $5.50 |
| May 12, 2026 | Canaccord Genuity | Maintained | Buy | $6.00 |
| May 7, 2026 | Needham | Maintained | Buy | $5.00 |
| Mar 2, 2026 | Oppenheimer | Maintained | Outperform | $6.00 |
| Feb 26, 2026 | Truist Securities | Maintained | Buy | $6.00 |
| Feb 26, 2026 | UBS | Maintained | Buy | $5.00 |
| Feb 26, 2026 | Citigroup | Maintained | Buy | $4.00 |
| Feb 25, 2026 | BTIG | Maintained | Buy | $8.00 |
| Feb 25, 2026 | Keybanc | Downgraded | Overweight → Sector Weight | — |
| Feb 25, 2026 | RBC Capital | Maintained | Sector Perform | $3.00 |

## Frequently Asked Questions

### What is the price target for EVH stock?

The average 12-month analyst price target for Evolent Health (EVH) is $6.00, with a high estimate of $6.00 and a low of $6.00, across 5 analysts.

### Is EVH a buy, sell, or hold?

Analysts covering Evolent Health currently average a Buy rating: 11 buy, 3 hold and 0 sell, from 14 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for EVH?

The average price target of $6.00 implies 23.20% upside from the last price of $4.87.

### What is the latest analyst rating on EVH?

On Aug 18, 2026, JP Morgan maintained Evolent Health at Overweight with a price target of $6.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).